Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7077-7077
◽
Keyword(s):
Phase I
◽